Applied DNA Sciences (APDN) Misses Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.32 million versus the consensus estimate of $2.04 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer raises Microsoft target ahead of earnings amid demand strength
- Wells Fargo Upgrades Northwestern Corp. (NWE) to Overweight
- KeyBanc positive on Monolithic Power into earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
